Persistent and Late-Onset Disseminated Intravascular Coagulation Are Closely Related to Poor Prognosis in Patients with Sepsis
- PMID: 37871648
- DOI: 10.1055/a-2196-3630
Persistent and Late-Onset Disseminated Intravascular Coagulation Are Closely Related to Poor Prognosis in Patients with Sepsis
Abstract
Background: Septic-associated disseminated intravascular coagulation (DIC) is heterogeneous regarding prognosis and responsiveness to anticoagulant therapy.
Objectives: To investigate the relationship between the timing of development and recovery of DIC, its prognosis, and the difference in response to anticoagulant therapy in sepsis-associated DIC patients.
Methods: This study was performed with a dataset from a multicenter nationwide retrospective cohort study (J-Septic DIC registry) in Japan between 2011 and 2013 to reveal the subgroup "high risk of death in DIC" and investigate the relationship between anticoagulant use and mortality. Patients were assigned to four groups based on the International Society on Thrombosis and Haemostasis-overt DIC status at days 1 and 3: non-DIC (-/-), early-recovered DIC (+/-), late-onset DIC (-/+), and persistent DIC (+/+).
Results: A total of 1,922 patients were included. In-hospital mortality in persistent and late-onset DIC patients was significantly higher than in patients with non-DIC and early-recovered DIC. This finding indicates that persistent DIC and late-onset DIC were a poor-prognosis subgroup, "high-risk" DIC. Meanwhile, patients with high-risk DIC treated with anticoagulants had significantly better outcomes than those without anticoagulants after adjusting for confounding factors.
Conclusion: This study showed that individuals with a high risk of death, persistent DIC, and late-onset DIC were a poor-prognostic subgroup in septic DIC; however, high-risk DIC is also a subgroup that can obtain more benefits from anticoagulant therapy.
Thieme. All rights reserved.
Conflict of interest statement
K.Y. has received research grants from Asahi Kasei Pharma and Japan Blood Products Organization. T.I has received a research grant from JIMRO and has participated in advisory boards of Japan Blood Products Organization and Toray Medical.
Similar articles
-
Identifying Sepsis Populations Benefitting from Anticoagulant Therapy: A Prospective Cohort Study Incorporating a Restricted Cubic Spline Regression Model.Thromb Haemost. 2019 Nov;119(11):1740-1751. doi: 10.1055/s-0039-1693740. Epub 2019 Aug 13. Thromb Haemost. 2019. PMID: 31408900
-
Proposal and Validation of a Clinically Relevant Modification of the Japanese Association for Acute Medicine Disseminated Intravascular Coagulation Diagnostic Criteria for Sepsis.Thromb Haemost. 2024 Nov;124(11):1003-1012. doi: 10.1055/s-0044-1786808. Epub 2024 May 10. Thromb Haemost. 2024. PMID: 38729189 Free PMC article.
-
Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan.Crit Care. 2016 Jul 29;20(1):229. doi: 10.1186/s13054-016-1415-1. Crit Care. 2016. PMID: 27472991 Free PMC article. Clinical Trial.
-
Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials.J Thromb Haemost. 2016 Mar;14(3):518-30. doi: 10.1111/jth.13230. Epub 2016 Feb 1. J Thromb Haemost. 2016. PMID: 26670422 Review.
-
Optimal patient selection for anticoagulant therapy in sepsis: an evidence-based proposal from Japan.J Thromb Haemost. 2018 Mar;16(3):462-464. doi: 10.1111/jth.13946. Epub 2018 Jan 29. J Thromb Haemost. 2018. PMID: 29316171 Review.
Cited by
-
Determining prognostic indicator for anticoagulant therapy in sepsis-induced disseminated intravascular coagulation.J Intensive Care. 2024 Jun 24;12(1):24. doi: 10.1186/s40560-024-00739-x. J Intensive Care. 2024. PMID: 38915122 Free PMC article.
-
The transition of the criteria for disseminated intravascular coagulation and the targeted patients in randomized controlled trials over the decades: a scoping review.Thromb J. 2024 Dec 23;22(1):112. doi: 10.1186/s12959-024-00681-w. Thromb J. 2024. PMID: 39716150 Free PMC article.
-
Association analysis of sepsis progression to sepsis-induced coagulopathy: a study based on the MIMIC-IV database.BMC Infect Dis. 2025 Apr 21;25(1):573. doi: 10.1186/s12879-025-10972-w. BMC Infect Dis. 2025. PMID: 40259248 Free PMC article.
-
A comparison of disseminated intravascular coagulation scoring systems and their performance to predict mortality in sepsis patients: A systematic review and meta-analysis.PLoS One. 2025 Jan 16;20(1):e0315797. doi: 10.1371/journal.pone.0315797. eCollection 2025. PLoS One. 2025. PMID: 39821194 Free PMC article.
-
Machine learning models can predict cancer-associated disseminated intravascular coagulation in critically ill colorectal cancer patients.Front Pharmacol. 2024 Nov 20;15:1478342. doi: 10.3389/fphar.2024.1478342. eCollection 2024. Front Pharmacol. 2024. PMID: 39635429 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical